Groups » COVAX Clinical Development SWAT TEAM Workshops Group
The COVAX Clinical Development SWAT Team is organising workshops on COVID-19 on an ongoing basis. This group and forum provides the opportunity to continue discussions online or to just send a feedback on the workshops. Group members may even send in questions or suggestions ahead of the workshops. We look forward to fruitful discussions and to building a community of researchers, developers and regulators dedicated to contributing towards solutions to the pandemic.
| Topic | Started | Latest post | |
|---|---|---|---|
|
Workshop 'Multivalent COVID-19 vaccines to help address emergence of variants: CMC and Clinical implications' 14 April 2021 Please join us today for the above workshop. Registration is ... |
3 years ago By: Sonja Henne |
1 Replies |
3 years ago By: Sonja Henne |
|
Workshop 25 March 2021 'SARS-CoV2 variants - Practical considerations for accelerated clinical development in light of current regulatory guidance We hope you have found the webinar beneficial and would ... |
3 years ago By: Sonja Henne |
0 Replies | No posts |
|
Workshop 25 March 2021 'SARS-CoV2 variants - Practical considerations for accelerated clinical development in light of current regulatory guidance We are looking forward to the next one in our ... |
3 years ago By: Sonja Henne |
0 Replies | No posts |
|
Webinar 25 Feb 21 - Immune Correlates, SARS-CoV-2 Variants and ‘mix & match’ We are looking forward to our next webinar 'Immune Correlates, ... |
3 years ago By: Sonja Henne |
4 Replies |
3 years ago By: pauloloo |
|
Part 2: Clinical development gaps We would welcome anybody interested in participating in the above ... |
3 years ago By: Sonja Henne |
2 Replies |
3 years ago By: Sonja Henne |
|
In what circumstances would it be ethical to compare a known effective vaccine with an experimental vaccine of unknown efficacy ...in persons/populations/countries who would otherwise be eligible for the effective ... |
3 years ago By: Sonja Henne |
0 Replies | No posts |
|
Which Correlates of Protection should be discussed? |
3 years ago By: Sonja Henne |
0 Replies | No posts |
|
What kind of data is needed to establish the effectiveness of a schedule is different than that received the EUA/licensure? And what should be the size of safety database for ... |
3 years ago By: Sonja Henne |
0 Replies | No posts |
|
Part 1: Path to approval of additional Covid-19 vaccines We would welcome anybody interested in participating in the above ... |
3 years ago By: Sonja Henne |
4 Replies |
3 years ago By: Sonja Henne |
|
New Call for Proposals to rapidly generate additional clinical research on COVID-19 vaccines https://cepi.net/news_cepi/cepi-funding-call-launches-to-rapidly-generate-additional-clinical-research-on-covid-19-vaccines/ Please let us know if you have any questions ... |
3 years ago By: Sonja Henne |
0 Replies | No posts |